+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Calcium supplements in people with osteoporosis: Should not be given without concomitant treatment for osteoporosis



Calcium supplements in people with osteoporosis: Should not be given without concomitant treatment for osteoporosis



BMJ 341(7767): 260-261




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063895318

Download citation: RISBibTeXText

DOI: 10.2307/20734987


Related references

Calcium supplements in people with osteoporosis. BMJ 341: C3856, 2010

Ongoing research on concomitant treatment with estrogen, corticosteroid-induced osteoporosis male osteoporosis and orthopaedic indications. Osteoporosis International 6(1 Suppl.): 311-311, 1996

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. Cmaj 155(7): 935-939, 1996

The efficacy of combined use of 1 alpha-hydroxyvitamin D3 with calcium supplements in the treatment of osteoporosis. Nihon Seikeigeka Gakkai Zasshi 62(8): 723-732, 1988

Public health implications of the use of calcium supplements in the treatment of osteoporosis and hypertension. FASEB Journal 7(3-4): A732, 1993

The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis. Calcified Tissue Research 22(Suppl.): 236-240, 1977

Vitamin D supplements appropriate for preventing osteoporosis? - vitamin D supplements only in case of deficiency and as a partial aspect of osteoporosis prevention. Deutsche Medizinische Wochenschrift 139(9): 416, 2014

Reasons for discontinuating osteoporosis treatment Results from the Spanish compliance osteoporosis study in postmenopausal osteoporosis. Calcified Tissue International 72(4): 385, 2003

Baseline characteristics and reasons for initiating osteoporosis treatment Results from the Spanish compliance osteoporosis study in postmenopausal osteoporosis. Calcified Tissue International 72(4): 384, 2003

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis. Cmaj 155(7): 962-965, 1996

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis. Cmaj 155(7): 945-948, 1996

Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors. Drugs and Aging 30(12): 1029-1038, 2014

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. Cmaj 155(7): 955-961, 1996

Initial treatment trends in patient with osteoporosis: use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice. Reumatologia Clinica 8(1): 3-9, 2012

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Current Medical Research and Opinion 28(3): 475-491, 2012